Urachal Signet Ring Cell Carcinoma: A Clinicopathological Analysis of 28 Cases
Current Oncology · 07.03.2026 · 33 (3) · 153
DOI: 10.3390/curroncol33030153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 07.03.2026. Verfasst von Natalie South und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Medicine and Health Sciences, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland. Hauptthemen laut MEDLINE: Carcinoma, Signet Ring Cell, Urinary Bladder Neoplasms. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Urachal carcinoma is a rare malignancy comprising less than 1% of all bladder cancers. The signet-ring cell subtype is particularly aggressive and poses significant diagnostic and therapeutic challenges.
Methods
A retrospective review of urachal carcinoma cases from 1989 to 2023 was conducted using data from BC Cancer and MD Anderson Cancer Center. The study analyzed 75 patients, including 28 signet-ring cell carcinoma (SRCC) cases and a control group of 47 non-SRCC cases, to compare survival patterns, treatment outcomes, and histopathological features.
Results
Clinically, the SRCC subtype was associated with advanced stage at presentation (pT3/pT4) and a higher recurrence rate (82% vs. 53%; p = 0.01). Survival analysis demonstrated worse outcomes for the SRCC cohort, with a five-year cancer-specific survival (CSS) of 39% compared to 64% in the non-signet group (p = 0.053). Partial cystectomy remained the primary surgical approach for both cohorts. Adjuvant chemotherapy was administered more often in SRCC cases (86% vs. 47%).
Conclusions
By providing a comprehensive multi-institutional analysis, this study establishes urachal SRCC as a distinct clinical entity with a strong independent prognostic significance. Despite aggressive multimodal management, it carries a poorer prognosis compared to urachal non-SRCC, emphasizing the need for subtype-specific therapeutic guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of Medicine and Health Sciences, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
- Department of Pathology and Laboratory Medicine, BC Cancer, Vancouver, BC V6T 1Z1, Canada.
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
- Faculty of Science, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
- Department of Pathology and Laboratory Medicine, Surrey Memorial Hospital, Surry, BC V3V 1Z2, Canada.
- Department of Pathology, MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Natalie South, Ioana Maria Mihai
Zitieren
APA
South, N., Mihai, I. M., Wang, V., Agoumi, M., Guo, C., & Wang, G. (2026). Urachal Signet Ring Cell Carcinoma: A Clinicopathological Analysis of 28 Cases. Current Oncology, 33(3), 153. https://doi.org/10.3390/curroncol33030153
Vancouver
South N, Mihai IM, Wang V, Agoumi M, Guo C, Wang G. Urachal Signet Ring Cell Carcinoma: A Clinicopathological Analysis of 28 Cases. Current Oncology. 2026;33(3):153. doi:10.3390/curroncol33030153
BibTeX
@article{South2026,
author = {South, Natalie and Mihai, Ioana Maria and Wang, Vickie and Agoumi, Mehdi and Guo, Charles and Wang, Gang},
title = {Urachal Signet Ring Cell Carcinoma: A Clinicopathological Analysis of 28 Cases},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {3},
pages = {153},
doi = {10.3390/curroncol33030153}
}
EUVIMED